Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
VBI Vaccines Inc/BC (VBIV)
Sector: Healthcare; Industry: Biotechnology

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology in Israel, the United States, and internationally. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for a functional cure of chronic hepatitis B. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the target virus to elicit a potent immune response. It primarily serves physicians and pharmacists through direct sales. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-12-03 Beattie Nell Chief Business Officer Buy 8,200 $2.45 $20,083 No
2021-12-01 PERCEPTIVE ADVISORS LLC 10%-Owner Sell 2,707,463 $3.31 $8,961,703 No
2021-06-29 PERCEPTIVE ADVISORS LLC 10%-Owner Sell 646,257 $3.80 $2,455,777 No
2021-06-09 PERCEPTIVE ADVISORS LLC 10%-Owner Sell 1,422,567 $4.00 $5,690,268 Yes
2020-04-24 PERCEPTIVE ADVISORS LLC 10%-Owner Buy 9,090,909 $1.10 $10,000,000 No
2019-10-04 Diaz-Mitoma Francisco Chief Medical Officer Buy 54,500 $0.50 $27,250 No
2019-10-01 McNulty Christopher CFO and Head of BD Buy 12,000 $0.47 $5,676 No
2019-10-01 Beattie Nell Chief Business Officer Buy 10,000 $0.48 $4,822 No
2019-09-30 Baxter Jeff CEO, President Buy 150,000 $0.50 $75,450 No
2019-09-23 PERCEPTIVE ADVISORS LLC 10%-Owner Buy 20,000,000 $0.50 $10,000,000 No
2019-06-27 Diaz-Mitoma Francisco Chief Medical Officer Buy 8,000 $1.07 $8,560 No
2019-06-20 Diaz-Mitoma Francisco Chief Medical Officer Buy 52,000 $0.87 $45,180 No
2019-06-18 PERCEPTIVE ADVISORS LLC 10%-Owner Buy 1,000,000 $0.65 $650,000 No
2019-06-19 Beattie Nell Chief Business Officer Buy 8,000 $0.74 $5,886 No
2019-06-19 Baxter Jeff CEO, President Buy 144,000 $0.73 $105,336 No
2019-06-17 PERCEPTIVE ADVISORS LLC 10%-Owner Buy 1,000,000 $0.62 $618,000 No
2018-12-17 Kariv Tomer Director Buy 1,428,571 $1.40 $1,999,999 No
2018-12-13 PERCEPTIVE ADVISORS LLC 10%-Owner Buy 14,285,714 $1.40 $20,000,000 No
2018-08-06 Baxter Jeff CEO, President Buy 8,100 $1.93 $15,607 No
2018-08-03 Diaz-Mitoma Francisco Chief Medical Officer Buy 9,000 $2.13 $19,200 No
2018-08-03 Baxter Jeff CEO, President Buy 13,500 $2.01 $27,111 No
2018-08-03 Beattie Nell Chief Business Officer Buy 2,000 $2.01 $4,011 No
2018-07-31 Baxter Jeff CEO, President Buy 16,800 $2.28 $38,237 No
2018-05-24 Baxter Jeff CEO, President Buy 11,000 $2.99 $32,890 No
2018-05-11 Diaz-Mitoma Francisco Chief Medical Officer Buy 10,000 $3.05 $30,475 No
2018-05-11 Baxter Jeff CEO, President Buy 7,100 $2.91 $20,661 No
2017-12-12 Baxter Jeff CEO, President Buy 10,000 $3.89 $38,854 No
2017-11-28 Baxter Jeff CEO, President Buy 15,000 $4.75 $71,250 No
2017-10-30 Opko Health, Inc. 10%-Owner Buy 655,738 $3.05 $2,000,001 No
2017-10-30 GILLIS STEVEN Director Buy 300,000 $3.05 $915,000 No

Insider Smart

SERVICE CORP INTERNATIONAL (SCI) - WALTRIP W BLAIR, Director of $SCI made a buy at 34.65, was he convinced the bottom of the box is a strong support? Well, seems he is not wrong.

Insider Smart

Mohawk Group Holdings, Inc. (MWK) - Multiple insiders bought MWK in June around $5, stock moved sideways for a month then made a 60% jump in 10 days. Patience is the key.